Long-Term Effect of Immediate Versus Delayed Fingolimod Treatment in Young Adult Patients with Relapsing –Remitting Multiple Sclerosis: Pooled Analysis from the FREEDOMS/FREEDOMS II Trials

ConclusionIn young adult patients with MS, immediate versus delayed fingolimod treatment was associated with improved disease outcomes and greater long-term benefits in both disease activity and disability progression.FundingNovartis Pharma AG.

http://link.springer.com/10.1007/s40120-019-0146-z

Source: Neurology and Therapy - July 18, 2019 Category: Neurology Source Type: research